Clinical efficacy and safety: cardiovascular system

  • Email
  • Help

The European Medicines Agency’s scientific guidelines on the clinical evaluation of human medicines used in conditions affecting the cardiovascular system help medicine developers prepare marketing authorisation applications.

If you have comments on a document which is open for consultation, use the form for submission of comments on scientific guidelines.

Please submit your comments to the following email address: cvswpsecretariat@ema.europa.eu.

For a complete list of scientific guidelines currently open for consultation, see Public consultations.


Hypertension

Guidelines


Lipid disorders

Guidelines


Pulmonary arterial hypertenstion

Guidelines


Arrythmias

Guidelines


Venous thromboembolism

Guidelines


Heart failure

Guidelines


Coronary artery disease

Guidelines


Questions and answers


Other

Guidelines


Reflection papers


Position statements

How useful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings

Related content